Hervé Perron active positions
Companies | Position | Start | End |
---|---|---|---|
GENEURO SA | Founder | 2005-12-31 | - |
Chief Tech/Sci/R&D Officer | 2005-12-31 | - | |
Director/Board Member | 2005-12-31 | - |
Career history of Hervé Perron
Former positions of Hervé Perron
Companies | Position | Start | End |
---|---|---|---|
GeNeuro Innovation SAS
GeNeuro Innovation SAS Miscellaneous Commercial ServicesCommercial Services Part of GeNeuro SA (Switzerland), GeNeuro Innovation SAS is a French company that specializes in developing therapeutic products for the treatment of neurological disorders such as multiple sclerosis, schizophrenia, and autoimmune disorders like diabetes. The company focuses on developing new therapeutics that address nervous system pathologies involving human endogenous retroviruses (HERVs). | Corporate Officer/Principal | - | - |
Biomerieux Stelhys
Biomerieux Stelhys Miscellaneous Commercial ServicesCommercial Services Biomerieux Stelhys provides research and development services for physical and natural sciences. The private company is based in Marcy-l'Étoile, France. | Corporate Officer/Principal | - | - |
Statistics
International
France | 3 |
Switzerland | 2 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Commercial Services | 3 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
GENEURO SA | Health Technology |
Private companies | 2 |
---|---|
Biomerieux Stelhys
Biomerieux Stelhys Miscellaneous Commercial ServicesCommercial Services Biomerieux Stelhys provides research and development services for physical and natural sciences. The private company is based in Marcy-l'Étoile, France. | Commercial Services |
GeNeuro Innovation SAS
GeNeuro Innovation SAS Miscellaneous Commercial ServicesCommercial Services Part of GeNeuro SA (Switzerland), GeNeuro Innovation SAS is a French company that specializes in developing therapeutic products for the treatment of neurological disorders such as multiple sclerosis, schizophrenia, and autoimmune disorders like diabetes. The company focuses on developing new therapeutics that address nervous system pathologies involving human endogenous retroviruses (HERVs). | Commercial Services |
- Stock Market
- Insiders
- Hervé Perron
- Experience